European Medicines Agency organising workshop on biosimilars

September 30, 2013 4:46 PM

The European Medicines Agency is holding a workshop on biosimilars on 31 October 2013.

The Agency is organising this workshop as part of its public-consultation exercise on its three draft revised overarching guidelines on biosimilars. These are:

The aim of this workshop is to bring together regulators and stakeholders to discuss the three draft revised guidelines, including comments received so far during the public consultation.

Presentations and discussions during the workshop will focus on the main topics identified through the comments received, including:

  • the choice of the reference product;
  • the concept of quality target product profile;
  • the stepwise approach to non-clinical programme;
  • biosimilar specific clinical model and endpoints.

The workshop will be live-streamed and recorded.

The European Medicines Agency will invite stakeholders who provided comments on the draft guidelines to participate in the workshop. There will be a limited number of places available. Expressions of interest can be sent to bmwp.secretariat@ema.europa.eu by 10 October 2013 using the registration form provided. Places available will be offered on a first-come-first-served basis.

 

Source: EMA

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!